Genxone SA
Genxone SA operates in Pharmaceuticals.
Market Cap & Net Worth: Genxone SA (GX1)
Genxone SA (WAR:GX1) has a market capitalization of $9.63K (zł40.06K) as of March 18, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #45046 globally and #458 in its home market, demonstrating a -26.95% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genxone SA's stock price zł4.31 by its total outstanding shares 9294 (9.29K).
Genxone SA Market Cap History: 2020 to 2026
Genxone SA's market capitalization history from 2020 to 2026. Data shows change from $42.86K to $9.63K (-33.90% CAGR).
Genxone SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genxone SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of GX1 by Market Capitalization
Companies near Genxone SA in the global market cap rankings as of March 18, 2026.
Key companies related to Genxone SA by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3465 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #6393 globally with a market cap of $1.27 Billion USD ( ₩1.86 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7113 globally with a market cap of $1.05 Billion USD ( ₩1.54 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #7795 globally with a market cap of $890.75 Million USD ( ₩1.30 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3465 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩739000.00 |
| #6393 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.27 Billion | ₩89200.00 |
| #7113 | ST Pharm Co.Ltd | KQ:237690 | $1.05 Billion | ₩153400.00 |
| #7795 | Oscotec Inc | KQ:039200 | $890.75 Million | ₩54900.00 |
Genxone SA Historical Marketcap From 2020 to 2026
Between 2020 and today, Genxone SA's market cap moved from $42.86K to $ 9.63K, with a yearly change of -33.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł9.63K | +8.02% |
| 2025 | zł8.92K | -35.65% |
| 2024 | zł13.86K | +15.24% |
| 2023 | zł12.03K | -47.36% |
| 2022 | zł22.84K | -47.95% |
| 2021 | zł43.89K | +2.40% |
| 2020 | zł42.86K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Genxone SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.63K USD |
| MoneyControl | $9.63K USD |
| MarketWatch | $9.63K USD |
| marketcap.company | $9.63K USD |
| Reuters | $9.63K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.